Skip to main content
. 2019 Nov 1;15:3051–3060. doi: 10.2147/NDT.S218450

Table 2.

Summary Of The Linear Regression Of Significant Predictors For PTGI In Patients With Breast Cancer

Variable Unadjusted Model Adjusted Model
B SE β p-value R2 DW B SE β p-value VIF R2 DW
Age, years −0.057 0.029 −0.210 0.031* 0.03 1.83 0.33 1.87
BMI, kg/m2 −0.170 0.075 −0.190 0.046* 0.03 1.78 −1.080 0.538 −0.165 0.075* 1.02
Year of education 0.817 0.121 0.377 <0.001*** 0.13 1.69 1.852 0.603 0.272 0.003** 1.19
Diabetes 0.167 0.052 −0.221 0.0218* 0.04 1.80
Chemotherapy 0.174 0.057 0.256 0.0074** 0.06 1.93 13.615 4.793 0.248 0.005** 1.15
Hormone therapy 0.333 0.064 0.223 0.0201* 0.04 1.81
Family support (Family APGAR) 0.421 0.084 0.210 0.0295* 0.03 1.89 2.106 0.675 0.259 0.024** 1.04
Anxiety symptoms (HADS-A) −0.141 0.018 0.272 0.0044** 0.07 1.72 1.873 0.626 0.271 0.035* 1.24

Notes: Adjusted model was applied using a stepwise linear regression. *P < 0.05, **P < 0.01, ***P < 0.001.

Abbreviations: β, standardized regression coefficients; B, regression coefficient; HADS-A, Hospital Anxiety and Depression Scale-Anxiety symptoms; PTGI, Post-traumatic Growth Inventory; SE, standard error; VIF, variance inflation factor.